Papadopoulos I, Weichert-Jacobsen K, Wand H
Abteilung Urologie im Klinikum, Universität Kiel.
Z Urol Nephrol. 1990 May;83(5):233-7.
From 1986 to 1989 papaverine was used alone or in combination with phentolamine in 165 patients in diagnosis and treatment of erectile dysfunction. In 14 patients a prolonged erection did occur after diagnostical introduction of SKAT therapy. Treatment consisted of intracavernous injection of 2-4 mg metaraminol, partly additional by puncture of cavernous bodies and evacuation of viscous blood. As single complication of metaraminol injection a hypertensive crisis could observed. A glando-cavernous shunt was not necessary in any case. After exact dosage adjustment the danger of drug-induced priapism is low.
1986年至1989年期间,165例勃起功能障碍患者单独使用罂粟碱或联合酚妥拉明进行诊断和治疗。在14例患者中,SKAT疗法诊断性引入后确实出现了持续性勃起。治疗方法包括海绵体内注射2 - 4毫克间羟胺,部分患者还通过穿刺海绵体并抽出黏稠血液进行辅助治疗。间羟胺注射的唯一并发症是观察到高血压危象。在任何情况下都不需要进行腺体 - 海绵体分流术。经过精确的剂量调整后,药物性阴茎异常勃起的风险较低。